“…The incidence of hepatolithiasis with cholangiocarcinoma is reported to be 4–11% of the total cases of hepatolithiasis: 2–11 not as rare as previously considered 3,4 , 12,13 . There have been few studies on the influence of hepatolithiasis on the occurrence of cholangiocarcinoma 14,15 .…”
The clinicopathological features of cholangiocarcinoma with concomitant hepatolithiasis showed few differences from that without hepatolithiasis. Resectability was the only predictor that favored a good prognosis.
“…The incidence of hepatolithiasis with cholangiocarcinoma is reported to be 4–11% of the total cases of hepatolithiasis: 2–11 not as rare as previously considered 3,4 , 12,13 . There have been few studies on the influence of hepatolithiasis on the occurrence of cholangiocarcinoma 14,15 .…”
The clinicopathological features of cholangiocarcinoma with concomitant hepatolithiasis showed few differences from that without hepatolithiasis. Resectability was the only predictor that favored a good prognosis.
These survival differences may be attributed to delayed diagnosis, lower diagnostic rate and relatively fewer curative resections in the patients with stone-containing cholangiocarcinoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.